Q4 2022 Earnings

Events

Investor Relations

Press Releases

27 Feb '24
Expects Not to File Required Financial Statements by Nasdaq’s February 27, 2024 Deadline Working Diligently to File Required Financial Statements and Restore Listing Adopts Limited Duration Stockholder Rights Plan CHICAGO --(BUSINESS WIRE)--Feb. 27, 2024-- Veradigm Inc.
27 Feb '24
Veradigm to Leverage ScienceIO’s Leading Healthcare Artificial Intelligence (AI) Platform on the Company’s Large-Scale, High-Quality Data Set to Build Advanced, Private Language Models for Healthcare Expected to Provide Highly Differentiated and More Advanced Products to Veradigm Customers

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Contact Investor Relations

Jenny Gelinas
Vice President, Investor Relations
jenny.gelinas@veradigm.com